Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

• Päätekijät: P.L. Meroni (Tekijä), T. Avcin (Tekijä), V. Medeghini (Tekijä), A. Meini (Tekijä), A. Lojacono (Tekijä), M. Frassi (Tekijä), M. Nuzzo (Tekijä), Z. Shums (Tekijä), W.L. Binder (Tekijä), G.L. Norman (Tekijä), M. Motta (Tekijä), L. Andreoli (Tekijä), C. Nalli (Tekijä), A. Tincani (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: PAGEPress Publications, 2011-09-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Objective: Anti-b2 GPI are a formal laboratory criterion for the antiphospholipid syndrome (APS). They were demonstrated to be a risk factor for thrombosis and fetal losses but can also be detected in patients with systemic autoimmune disease (SAD), in healthy adults individuals and pre-school child...